0,1
"7.5.3	
Summary of evidence and recommendation on locally-recurrent RCC after treatment of 
localised disease",
Recommendations,Strength rating
Base follow-up after treatment of localised RCC on the risk of recurrence.,Strong
"Base risk of recurrence stratification on validated subtype-specific models such as the 
Leibovich Score for ccRCC, or the University of California Los Angeles integrated staging 
system for non-ccRCC.",Weak
"Intensify follow-up in patients after NSS for tumours > 7 cm or in patients with a positive 
surgical margin.",Weak
"Consider curtailing follow-up when the risk of dying from other causes is double that of the 
RCC recurrence risk.",Weak
